Jeffrey M. Leiden serves as Executive at ABBOTT LABORATORIES, where they oversee executive responsibilities. Since joining the company, Jeffrey M. Leiden has executed 311 insider transactions totaling $545.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 14, 2011 involved receiving (via award) 50,017 shares valued at $0.
Jeffrey M. Leiden currently holds 34,797 shares of ABBOTT LABORATORIES (ABT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey M. Leiden has been a net seller of ABT stock. They have purchased $100.1K and sold $545.0M worth of shares.
Jeffrey M. Leiden's most recent insider trade was on Dec 14, 2011, when they sold 50,017 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 4, 2010 | VRTX | $49.9K | Purchase | 1,300 | $38.40 | Discretionary |
| Apr 23, 2010 | VRTX | $50.2K | Purchase | 1,300 | $38.60 | Discretionary |
| Mar 24, 2006 | ABT | $0 | Disposition | 100,000 | $N/A | Discretionary |
| Mar 24, 2006 | ABT | $4.0M | Payment | 91,846 | $43.68 | Discretionary |
| Feb 18, 2006 | ABT | $269.4K | Payment | 6,102 | $44.15 | Discretionary |
| Feb 17, 2006 | ABT | $4.4M | Award | 100,000 | $44.16 | Discretionary |
| Feb 17, 2006 | ABT | $88.8K | Sale | 2,000 | $44.41 | Discretionary |
| Jan 31, 2006 | ABT | $2.8M | Option Exercise | 83,544 | $33.23 | Discretionary |
| Jan 31, 2006 | ABT | $3.0M | Payment | 70,249 | $42.94 | Discretionary |